Posts
August 22 2017
Lakeland Industries, Inc. announced the closing of their Underwritten offering in the amount of $10,005,000. EG&S acted as counsel to the Underwriter.
August 21 2017
Avista Healthcare Public Acquisition Corp. announced that it has entered into a definitive merger agreement with Envigo International Holdings, Inc., a leading early stage non-clinical contract research organization offering a diverse set of non-clinical discovery and safety assessment services as well as laboratory animal science tools. EG&S acted as special SPAC counsel to Envigo.
August 18 2017
EG&S acted as counsel to Movie Pass, Inc. which recently announced that it has entered into an agreement with Helios and Matheson Analytics Inc. pursuant to which Helios will buy 51% of the outstanding stock of MoviePass. MoviePass, a movie subscription technology company established in 2011, has been led by Netflix co-founder and former Redbox president Mitch Lowe as CEO since June 2016, along with MoviePass co-founder Stacy Spikes. The transaction will be valued at up to $27,000,000.
August 18 2017
I-AM Capital Acquisition Company announced the closing of its initial public offering in the amount of $50,000,000. EGS acted as counsel to I-Am.
August 18 2017
Pacific Special Acquisition Corp. announced the closing of its business combination with Borqs International Holding Corp., a global leader in software and IoT products providing customizable, differentiated and scalable Android-based smart connected devices and cloud service solutions. EG&S acted as counsel to Pacific.
August 17 2017
Richard P. Kaye, a member of the Firm, along with senior litigation associate John Horgan, and litigation associates Joanna Cohen and Anne O’Malley, successfully vacated a judgement of approximately $500,000 against a client. After oral argument and two evidentiary hearings, EGS attorneys established that the client had never signed a retainer agreement with the attorney who purported to represent him in Court; having never been served personally and never appeared through counsel, the Court had no jurisdiction over him to enter the $500,000 judgment.
August 16 2017
Enteromedics Inc. announced the closing of their Underwritten offering in the amount of $18,295,000. EG&S acted as counsel to the Underwriter.
August 11 2017
BioAmber Inc. announced the closing of their Underwritten offering in the amount of $11,000.000. EG&S acted as counsel to the Underwriter.